Morgan Stanley’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
25,091
+14,668
| +141% | +$63.2K | ﹤0.01% | 6098 |
|
|
2025
Q1 | $39K | Sell |
10,423
-223,790
| -96% | -$837K | ﹤0.01% | 6355 |
|
|
2024
Q4 | $2.38M | Buy |
234,213
+225,970
| +2,741% | +$2.29M | ﹤0.01% | 4581 |
|
|
2024
Q3 | $103K | Sell |
8,243
-5,091
| -38% | -$63.4K | ﹤0.01% | 6001 |
|
|
2024
Q2 | $174K | Sell |
13,334
-6,318
| -32% | -$82.2K | ﹤0.01% | 5742 |
|
|
2024
Q1 | $445K | Sell |
19,652
-93,035
| -83% | -$2.11M | ﹤0.01% | 5366 |
|
|
2023
Q4 | $1.46M | Buy |
112,687
+43,056
| +62% | +$559K | ﹤0.01% | 5116 |
|
|
2023
Q3 | $1.4M | Buy |
69,631
+41,477
| +147% | +$834K | ﹤0.01% | 4607 |
|
|
2023
Q2 | $756K | Sell |
28,154
-20,292
| -42% | -$545K | ﹤0.01% | 5002 |
|
|
2023
Q1 | $2.83M | Sell |
48,446
-37,516
| -44% | -$2.19M | ﹤0.01% | 4235 |
|
|
2022
Q4 | $4.38M | Buy |
85,962
+13,970
| +19% | +$712K | ﹤0.01% | 3870 |
|
|
2022
Q3 | $5.9M | Sell |
71,992
-87,121
| -55% | -$7.14M | ﹤0.01% | 3534 |
|
|
2022
Q2 | $10.8M | Sell |
159,113
-28,391
| -15% | -$1.92M | ﹤0.01% | 2999 |
|
|
2022
Q1 | $20.7M | Buy |
187,504
+116,463
| +164% | +$12.9M | ﹤0.01% | 2077 |
|
|
2021
Q4 | $6.85M | Sell |
71,041
-55,155
| -44% | -$5.32M | ﹤0.01% | 3382 |
|
|
2021
Q3 | $11M | Buy |
126,196
+16,684
| +15% | +$1.46M | ﹤0.01% | 2779 |
|
|
2021
Q2 | $17M | Sell |
109,512
-3,720
| -3% | -$576K | ﹤0.01% | 2335 |
|
|
2021
Q1 | $17.9M | Buy |
113,232
+63,704
| +129% | +$10.1M | ﹤0.01% | 2032 |
|
|
2020
Q4 | $11.5M | Buy |
49,528
+20,489
| +71% | +$4.76M | ﹤0.01% | 2363 |
|
|
2020
Q3 | $6.36M | Buy |
29,039
+17,078
| +143% | +$3.74M | ﹤0.01% | 2479 |
|
|
2020
Q2 | $3.4M | Buy |
11,961
+7,989
| +201% | +$2.27M | ﹤0.01% | 3065 |
|
|
2020
Q1 | $1.15M | Sell |
3,972
-3,566
| -47% | -$1.03M | ﹤0.01% | 3847 |
|
|
2019
Q4 | $2.17M | Sell |
7,538
-3,438
| -31% | -$989K | ﹤0.01% | 3971 |
|
|
2019
Q3 | $1.58M | Buy |
10,976
+3,298
| +43% | +$476K | ﹤0.01% | 3986 |
|
|
2019
Q2 | $690K | Sell |
7,678
-3,276
| -30% | -$294K | ﹤0.01% | 4433 |
|
|
2019
Q1 | $960K | Buy |
10,954
+5,230
| +91% | +$458K | ﹤0.01% | 4135 |
|
|
2018
Q4 | $804K | Sell |
5,724
-889
| -13% | -$125K | ﹤0.01% | 4444 |
|
|
2018
Q3 | $1.69M | Sell |
6,613
-605
| -8% | -$155K | ﹤0.01% | 4145 |
|
|
2018
Q2 | $1.84M | Sell |
7,218
-2,623
| -27% | -$668K | ﹤0.01% | 4154 |
|
|
2018
Q1 | $1.98M | Buy |
9,841
+5,179
| +111% | +$1.04M | ﹤0.01% | 4020 |
|
|
2017
Q4 | $671K | Buy |
4,662
+559
| +14% | +$80.5K | ﹤0.01% | 4809 |
|
|
2017
Q3 | $675K | Buy |
4,103
+2,034
| +98% | +$335K | ﹤0.01% | 4691 |
|
|
2017
Q2 | $281K | Sell |
2,069
-1,660
| -45% | -$225K | ﹤0.01% | 5146 |
|
|
2017
Q1 | $718K | Sell |
3,729
-3,108
| -45% | -$598K | ﹤0.01% | 4613 |
|
|
2016
Q4 | $964K | Buy |
6,837
+5,645
| +474% | +$796K | ﹤0.01% | 4488 |
|
|
2016
Q3 | $175K | Buy |
1,192
+848
| +247% | +$124K | ﹤0.01% | 5075 |
|
|
2016
Q2 | $35K | Sell |
344
-1,089
| -76% | -$111K | ﹤0.01% | 5653 |
|
|
2016
Q1 | $192K | Buy |
1,433
+141
| +11% | +$18.9K | ﹤0.01% | 4996 |
|
|
2015
Q4 | $257K | Sell |
1,292
-7,604
| -85% | -$1.51M | ﹤0.01% | 4952 |
|
|
2015
Q3 | $1.41M | Buy |
8,896
+6,846
| +334% | +$1.08M | ﹤0.01% | 3821 |
|
|
2015
Q2 | $837K | Sell |
2,050
-1,799
| -47% | -$735K | ﹤0.01% | 4337 |
|
|
2015
Q1 | $1.77M | Buy |
3,849
+662
| +21% | +$304K | ﹤0.01% | 3687 |
|
|
2014
Q4 | $1.79M | Sell |
3,187
-49
| -2% | -$27.5K | ﹤0.01% | 3664 |
|
|
2014
Q3 | $1.7M | Buy |
3,236
+221
| +7% | +$116K | ﹤0.01% | 3576 |
|
|
2014
Q2 | $2.11M | Buy |
3,015
+2,003
| +198% | +$1.4M | ﹤0.01% | 3444 |
|
|
2014
Q1 | $469K | Sell |
1,012
-6,953
| -87% | -$3.22M | ﹤0.01% | 4606 |
|
|
2013
Q4 | $2.74M | Buy |
+7,965
| New | +$2.74M | ﹤0.01% | 3139 |
|